Where is Alembic located?

Alembic is headquartered in Vadodara, India. It is registered at ALEMBIC ROAD, BARODA, Gujarat, India, 390003.

How many employees does Alembic have?

As of May 31, 2026, the latest employee count at Alembic is 100.

Is Alembic a funded company?

Alembic is a funded company, having raised a total of $***** in its 1st and only funding round.

What is the annual revenue of Alembic?

Annual revenue of Alembic is ₹6,710Cr as on Mar 31, 2025.

Where does Alembic rank among its competitors?

Alembic ranks 62nd amongst 1284 active competitors, of which 75 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Johnson & Johnson, which secured $34M in Feb, 2025.

Who are the top competitors of Alembic?

Alembic's top competitors include AbbVie, Amgen and Gilead. Among them, Johnson & Johnson secured the most recent funding round in February, 2025.

Alembic - 2026 Company Profile, Competitors & Financials

Alembic is a public company based in Vadodara (India), founded in 1907. It operates as a Manufacturer of active pharmaceuticals ingredients. The company has 1284 active competitors, including 75 funded and 157 that have exited. Its top competitors include companies like AbbVie, Amgen and Gilead.

Company Details

Website: alembiclimited.com
Email ID: *****@alembic.co.in
Phone Number: +91 **********
Registered Address: ALEMBIC ROAD, BARODA, Gujarat, India, 390003

Key Metrics

Founded Year

1907

Location

Vadodara, India

Stage

Public

Ranked

62^nd among 1284 active competitors

Annual Revenue

₹6,710Cr as on Mar 31, 2025

Employee Count

100 as on May 31, 2026

Similar Companies

AbbVie & 1310 more

Exit Details

Public

View Alembic's full profile

Alembic is associated with 4 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count
ALEMBIC PHARMACEUTICALS LIMITED CIN: L24230GJ2010PLC061123 , India, Active	Jun 16, 2010	$794M (As on Mar 31, 2025)	17979 (As on Aug 31, 2025)
ALEMBIC LIMITED CIN: L26100GJ1907PLC000033 , India, Active	Jul 30, 1907	$35.1M (As on Mar 31, 2025)	274 (As on Oct 31, 2024)
ALEMBIC CITY LIMITED CIN: U70100GJ1994PLC021552 , India, Active	Mar 16, 1994	$4.54M (As on Mar 31, 2025)	-
SHRENO LIMITED CIN: U65922GJ2004PLC043742 , India, Amalgamated	Mar 08, 2004	$14.8M (As on Mar 31, 2023)	421 (As on Feb 28, 2025)

Alembic got listed on Jul 18, 1934.

Click here to take a look at Alembic's IPO in detail

Alembic is a funded company.

Alembic's employee count trend

Alembic has 100 employees as of May 26. Here is Alembic's employee count trend over the years:

Uncover Alembic's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Alembic include AbbVie, Amgen and Gilead. Here is the list of Top 10 competitors of Alembic, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AbbVie 2012, Chicago (United States), Public	Research-based biopharmaceutical company	$14.7B	Alcor Fund, Berkshire Hathaway & 8 others	81/100
2nd	Amgen 1980, Thousand Oaks (United States), Public	Developer of pharmaceutical products for treating multiple diseases	-	Amgen Business Development, Gershon Capital ... & 11 others	81/100
3rd	Gilead 1987, Foster City (United States), Acquired	Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others	-	BB Biotech, Temasek & 17 others	80/100
4th	Lilly 1876, Indianapolis (United States), Public	Developer of traditional pharmaceutical medicines	-	Alcor Fund, Gershon Capital & 11 others	79/100
5th	Johnson & Johnson 1886, New Brunswick (United States), Public	Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products	-	Alcor Fund, Western Technology Investment ... & 16 others	76/100
6th	Juno Therapeutics 2013, Seattle (United States), Acquired	Global biopharmaceutical company discovering, developing, and delivering innovative medicines	$317M	BB Biotech, RA Capital Management & 14 others	74/100
7th	Pfizer 1849, New York City (United States), Public	Provider of pharmaceutical products for multiple disease treatments	-	Alcor Fund, Benson Family Private Equity ... & 16 others	72/100
8th	Roivant Sciences 2014, New York City (United States), Public	Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases	$1.3B	SoftBank Vision Fund, NovaQuest Capital Management ... & 7 others	72/100
9th	Regeneron Pharmaceuticals 1988, Tarrytown (United States), Public	Developer of antibodies for the treatment of cancer, eye diseases, inflammatory diseases & others	-	BB Biotech, Gershon Capital & 7 others	71/100
10th	Novartis 1996, Basel (Switzerland), Public	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	Digital Pharma Lab, MT Capital & 9 others	70/100
62nd	Alembic 1907, Vadodara (India), Public	Manufacturer of active pharmaceuticals ingredients	-	-	54/100